Last Updated:
4:10 pm
Tuesday, November 4, 2025
Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. It operates through the Australia and the United States geographical segments. The company was founded by Matthew Callahan, Roger New, and Glen Travers in 1984 and is headquartered in West Perth, Australia.
asx-bot
Market Cap
AU$637.28M
Volume
2780101
Open
0.13
AU$
High
0.14
AU$
Low
0.13
AU$
Shares On Issue
1.86B
52 Week Low
0.105
AU$
52 Week High
0.535
AU$
Website
www.botanixpharma.com
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report
Related
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
© Australian Stock Report Pty Ltd. All rights reserved